Table 2.

Clinical characteristic of HCV-related HCC patients and donor graft subjects

	Donor liver grafts (LD, n = 14)	Recipient liver (LR, n = 10)	p
Age, yrs	62.1 ± 17.3	59.4 ± 1.8
Gender	–	8 M/2F
Diagnosis
HCC + Cirrosis +		8/10
HCV HCC +	–	1/10
Cirrosis + HBV		1/10
HCC + HCV
Genotype
1a		2/10
1b		3/10
2c	–	1/10
HCV-RNA-negative		2/10
Not typed		2/10
Total MELD score	0	8.6 ± 0.6
AST, UI/L	10.1 ± 1.5	110.0 ± 19.9	< 0.0001
ALT, UI/L	7.2 ± 1.6	100.4 ± 20.6	< 0.0001
GGT, UI/L	34.4 ± 12.7	139.2 ± 23.3	0.0004
Creatinine	1.2 ± 0.2	0.85 ± 0.06	ns

HCC hepatocellular carcinoma, HCV Hepatitis C virus, HBV Hepatitis B virus, MELD score model for end-stage liver disease, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT Gamma-glutamyl transferase